Cytek earnings
WebApr 12, 2024 · On Tuesday, March 7th, Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock. The shares were sold at an average price of $10.13, for a total value of $202,600.00. WebFeb 28, 2024 · Cytek Biosciences, Inc. provided earnings guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, …
Cytek earnings
Did you know?
WebFeb 23, 2024 · Cytek Biosciences expects full year 2024 revenue to be in the range of $160 million to $168 million. Webcast Information. Cytek will host a conference call to discuss the fourth quarter 2024 financial results on Wednesday, February 23, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time. A webcast of the conference call can be accessed at ... WebFind the latest Earnings Report Date for Cytek Biosciences, Inc. Common Stock (CTKB) at Nasdaq.com. Cytek Biosciences, Inc. Common Stock (CTKB) Earnings Report Date …
WebFeb 28, 2024 · Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Full year 2024 revenue increased 28%, or 34% on constant currency basis, compared to prior year Provides full year 2024 revenue guidance of $225 million to $235 million, or growth of 37% to 43% over full year 2024 WebFeb 28, 2024 · Cytek Biosciences, Inc. is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high …
WebCytek Biosciences’s upcoming earnings report date is May 10, 2024 which is in 37 days. How were Cytek Biosciences’s earnings last quarter? Cytek Biosciences released its earnings results on Feb 28, 2024. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.042 by $0.018. ... WebFeb 28, 2024 · Cytek Biosciences expects full year 2024 revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This …
WebApr 11, 2024 · Cytek Biosciences Inc’s price-earnings (P/E) ratio is currently at 568.0, which is high compared to the Advanced Medical Equipment & Technology industry median of 32.6. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.
WebFounded 1992 Status Public Employees 583 Stock Symbol CTKB Investments 4 Share Price $8.75 (As of Thursday Closing) General Information Description Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. greatest ohio state running backsWebApr 11, 2024 · The Zacks Consensus Estimate for Encompass Health’s 2024 earnings is pegged at $3.07 per share, indicating a 7.7% increase from the prior-year reported figure. The consensus mark for 2024... greatest oldies hitsWebFeb 28, 2024 · Cytek Biosciences, Inc. provided revenue guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 million of revenue contribution from the acquisition of Luminex's Flow Cytometry and … greatest oldies cdWebFeb 24, 2024 · Cytek Biosciences, Inc. (NASDAQ:NASDAQ:CTKB) Q4 2024 Earnings Conference Call February 23, 2024 5:00 PM ETCompany ParticipantsAlex Khan - Investor RelationsWenbin Jiang - Chief Executive... flipper zero tesla charge port githubWebMar 1, 2024 · Cytek Biosciences, Inc., which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $48.34 million for the quarter ended December 2024, missing the Zacks Consensus... flipper zero sub ghz repositoryWebAug 11, 2024 · Q2: 2024-08-10 Earnings Summary Press Release EPS of $0.03 misses by $0.01 Revenue of $40.16M (32.07% Y/Y) beats by $530.00K Cytek Biosciences, Inc. ( NASDAQ: CTKB) Q2 2024 Earnings... greatest ohio state quarterbacksWebApr 13, 2024 · Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CEO Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock in a transaction that occurred on Monday, April 10th.The stock was sold at an average price of $8.88, for a total transaction of $177,600.00. Following the sale, the chief executive officer now owns 7,684,439 shares … greatest old country hits